(a) The venue that adopts a policy for administering unassigned epinephrine auto-injectors shall submit a report no later than the 10th business day after the date an epinephrine auto-injection is administered, in accordance with the unassigned epinephrine auto-injector policy adopted under this subchapter. The report shall be submitted to the prescribing authorized healthcare provider and the Department of State Health Services (DSHS).
(b) Notifications to the commissioner of DSHS shall be submitted on the designated electronic form available on the DSHS School Health Program website, available at dshs.texas.gov.

Source Note: The provisions of this §40.17 adopted to be effective February 9, 2021, 46 TexReg 917